Skip to main content
Shakun Malik, MD, Oncology, Rockville, MD, NIH Clinical Center

ShakunMalikMD

Oncology Rockville, MD

Head & Neck Cancer, Thoracic Cancer

Physician

Dr. Malik is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Malik's full profile

Already have an account?

Education & Training

  • George Washington University
    George Washington UniversityFellowship, Hematology and Medical Oncology, 1994 - 1996
  • MedStar Health/Georgetown University Hospital
    MedStar Health/Georgetown University HospitalFellowship, Hematology and Medical Oncology, 1992 - 1994
  • UPMC Medical Education
    UPMC Medical EducationResidency, Internal Medicine, 1983 - 1986
  • Government Medical College of Jammu and Kashmire
    Government Medical College of Jammu and KashmireClass of 1979

Certifications & Licensure

  • DC State Medical License
    DC State Medical License 1996 - 2024
  • VA State Medical License
    VA State Medical License 2001 - 2024
  • MD State Medical License
    MD State Medical License 1996 - 2001
  • PA State Medical License
    PA State Medical License 1985 - 1992
  • GA State Medical License
    GA State Medical License 1984 - 1987
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Press Mentions

  • Cetuximab with Radiation Found to Be Inferior to Standard Treatment in HPV-Positive Oropharyngeal Cancer
    Cetuximab with Radiation Found to Be Inferior to Standard Treatment in HPV-Positive Oropharyngeal CancerAugust 23rd, 2018
  • Study: Cetuximab, Radiation Inferior to Standard HPV Throat Cancer Treatment
    Study: Cetuximab, Radiation Inferior to Standard HPV Throat Cancer TreatmentAugust 14th, 2018
  • Women, Elderly, Minorities Poorly Represented in Lung Cancer Drug Trial Data Submitted to US FDA
    Women, Elderly, Minorities Poorly Represented in Lung Cancer Drug Trial Data Submitted to US FDAJuly 6th, 2011

Hospital Affiliations